| Date | Company | Research Firm | Rating |
|
|
SNB | U-Capital | Aggregate |
|
|
JAMJOOM PHARMA | AlJazira Capital | Neutral |
|
|
ADVANCED | U-Capital | Hold |
|
|
YC | Sico | Buy |
|
|
SAUDI ARAMCO | AlJazira Capital | Overweight |
| Company / Shareholder | Current Holding | Prev. Holding | Change | Note |
|---|---|---|---|---|
|
Mohammed Hasan AlNaqool Sons Co.
Turki Mohamed Hassan Al-Naqool Al-Sabaiea
|
8.32% | 8.30% | 0.02% | |
|
Alwasail Industrial Co.
Abdulaziz Saleh Soliman El-Amry
|
7.12% | 7.21% | (0.09%) | |
|
Alwasail Industrial Co.
AbdulRahman A. Al-Mushaiqah
|
10.10% | 10.20% | (0.10%) | |
|
Al-Modawat Specialized Medical Co.
Qayyim Holding Company
|
58.98% | 59.87% | (0.89%) |
| Fund | NAV | YTD Return | |
|---|---|---|---|
| YAQEEN Gold Fund | 3,936,680.00 | 57.95% | |
| SNB Capital China Equity Fund | 10,202,649.00 | 33.11% | |
| SNB Capital Emerging Markets Index Fund | 119,371,698.00 | 24.93% | |
| ALINMA EMERGING MARKETS FUND | 55,548,611.00 | 23.67% | |
| SAB Invest China and India Equity Freestyle Fund | 19,656,842.00 | 20.93% | |
| SNB Capital Europe Index Fund | 152,460,396.00 | 18.71% | |
| SNB Capital Global Equity Fund | 5,093,463.00 | 18.07% | |
| AlJazira European Equities Fund | 45,842,858.00 | 16.95% | |
| SNB Capital Real Estate Fund | 57,934,488.00 | 16.95% | |
| AlJazira International Equities Fund | 132,575,396.00 | 15.82% | |
